Jefferies maintains buy call on Sun Pharma despite adverse guidance

Last Updated: Tuesday, July 21, 2015, 19:11

International brokerage house Jefferies said it is positive about Sun Pharma's strong key fundamentals, though its stock plunged 15 percent Tuesday, a day after the company warned of a deeper cut in bottomline and topline this year due to ongoing integration with Ranbaxy.

Sun Pharma slumps, heads towards biggest fall ever

Last Updated: Tuesday, July 21, 2015, 09:42

Shares in Sun Pharmaceutical Industries slumped 16 percent, heading towards their biggest daily fall ever, after the drugmaker on Monday said it sees 2016 sales flat at best.

Sun Pharma sees profit hit in FY16 on Ranbaxy integration

Last Updated: Monday, July 20, 2015, 21:50

Drug major Sun Pharma expects to take a hit on profit for the fiscal due to the charges related to the ongoing integration with Ranbaxy Laboratories.

Govt brings 39 more drugs under price control ambit

Last Updated: Thursday, July 16, 2015, 15:07

In a statement, regulator National Pharmaceutical Pricing Authority (NPPA) said "it has fixed/revised the prices in respect of 39 formulation packs..."

Commerce Ministry takes steps to boost pharma exports, sets up committee

Last Updated: Sunday, July 5, 2015, 11:49

Pharmaceutical sector has huge potential in terms of increasing exports, the Commerce Ministry is taking many measures to boost overseas shipments, a ministry official said.

Lupin acquires Russian drug firm Biocom

Last Updated: Thursday, July 2, 2015, 19:49

The company has acquired 100 per cent equity stake in ZAO Biocom in Russia subject to certain closing conditions, Lupin Ltd said in a statement without disclosing the financial details.

Government plans to set up Rs 500 cr VC fund for pharma industry

Last Updated: Sunday, June 28, 2015, 16:05

In the report, the task force has suggested that DoP may launch a scheme for giving financial assistance in form of soft loan or interest subsidy for upgradation of selected manufacturing facilities to the industry.

Lupin to beef up branded portfolio through alliances

Last Updated: Sunday, June 28, 2015, 15:51

"In 2015-16, the company remains committed to continuing to strengthen its branded portfolio with the launch of additional products by not only creating alliances but also developing its own pipeline and making strategic brand acquisitions in US markets," Lupin said in its annual report here.

Cipla heir apparent Kamil Hamied quits, bigger role for sister Samina

Last Updated: Wednesday, June 24, 2015, 18:31

Pharmaceuticals major Cipla Chairman Yusuf K Hamied's nephew Kamil Hamied, who has been understood to be groomed to take over the reins of the drug maker, has quit and his sister Samina Vaziralli has assumed an expanded role in the company.

China deports British investigator, wife in GSK case

Last Updated: Wednesday, June 17, 2015, 19:11

Chinese authorities on Wednesday deported a British investigator and his wife linked to a corruption case involving pharmaceutical giant GlaxoSmithKline (GSK), after releasing them from jail over a week ago, family sources told AFP.

Swedish pharma firm partners GVK Bio for drug research

Last Updated: Tuesday, June 16, 2015, 20:30

Sweden-based pharmaceutical firm Medivir has entered into a partnership with GVK Biosciences for drug research.

Elder Pharma eyes Rs 100 cr from global sales of Shelcal

Last Updated: Sunday, June 14, 2015, 13:14

The company is also looking to export another nutritional product, Thrive, a natural supplement that helps fight chronic metabolic disorders, he added. It is looking at strong prescription base in over 70 countries by March 2017.